DermatologyInvestigational

Argireline (Acetyl Hexapeptide-8)

Topical

Overview

Argireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles.

Mechanism of Action

This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency..

Research Summary & Key Findings

In vitro studies have shown that acetyl hexapeptide-8 can inhibit SNARE complex formation in cell-free systems. Small cosmetic trials have reported modest reductions in periorbital wrinkle depth with twice-daily topical application over 30 days, though methodological rigor and independent replication remain limited. No peer-reviewed clinical trials in dermatology journals have established standardized efficacy benchmarks.

Clinical Status

Investigational

Argireline (Acetyl Hexapeptide-8) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Topical

Related Peptides in Dermatology

Find a Provider

Find a verified provider who offers Argireline (Acetyl Hexapeptide-8) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Argireline (Acetyl Hexapeptide-8).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.